Provided by Tiger Trade Technology Pte. Ltd.

HANSOH PHARMA

34.000
+0.0800.24%
Volume:7.47M
Turnover:255.31M
Market Cap:206.18B
PE:31.28
High:34.640
Open:34.380
Low:33.960
Close:33.920
52wk High:43.939
52wk Low:27.882
Shares:6.06B
HK Float Shares:6.06B
Volume Ratio:0.59
T/O Rate:0.12%
Dividend:0.49
Dividend Rate:1.46%
EPS(LYR):1.087
ROE:19.40%
ROA:9.08%
PB:4.67
PE(LYR):31.28
PS:11.10

Loading ...

Movement Alert|HANSOH PHARMA Falls 3.22% in Regular Trading, Pharmaceutical Sector Under Broad Pressure as Post-Earnings Rally Continues to Retrace

Market Focus
·
Sep 10

Hansoh Pharmaceutical Group Stock Falls 3.5% in Hong Kong

Dow Jones
·
Sep 09

UBS: Mixed First-Half Results for Chinese Pharma Stocks, Names Simcere as Top Pick

Stock News
·
Sep 09

Movement Alert|HANSOH PHARMA Falls 3.1% in Regular Trading, Broad Pharma Sector Selloff Drags Down Stock

Market Focus
·
Sep 09

CLSA Highlights Return of Stock-Specific Drivers in China's Innovative Drug Sector, Sees Macro Swings as Entry Points

Stock News
·
Sep 09

Hansoh Pharma Says China NMPA Accepts BLA for HS-20093 in Small Cell Lung Cancer

Reuters
·
Sep 07

One-Day Surge, Three-Day Slump: Can Hansoh Pharma's Shares Climb Back to HK$40?

Stock News
·
Sep 02

HANSOH PHARMA's Investigational ADC for Small Cell Lung Cancer Wins NMPA Filing Acceptance

Stock News
·
Sep 02

Hansoh Pharma Says China NMPA Accepts HS-20093 BLA for Small Cell Lung Cancer

Reuters
·
Sep 02

Hansoh Pharmaceutical Group Stock Climbs 2.2% in Hong Kong

Dow Jones
·
Sep 02

Hansoh Pharmaceutical Says NMPA Accepts Biologics License Application of HS-20093

Reuters
·
Sep 02

CLSA Lifts Hansoh Pharma Target Price to HK$43.70, Reaffirms Outperform Rating

Deep News
·
Sep 01

Movement Alert|HANSOH PHARMA Declines 3.28% in Regular Trading, Post-Earnings Profit-Taking Extends Amid Pharma Sector Weakness

Market Focus
·
Sep 01

JPMorgan Reaffirms 'Overweight' on Hansoh Pharma, Lifts Target Price to HK$50

Stock News
·
Aug 31

Hansoh Pharmaceutical Group Stock Sheds 3.8% in Hong Kong

Dow Jones
·
Aug 31

Movement Alert|HANSOH PHARMA Falls 3.16% in Regular Trading, Post-Earnings Profit-Taking Meets Broad Pharma Sector Weakness

Market Focus
·
Aug 31

Here's What Analysts Are Forecasting For Hansoh Pharmaceutical Group Company Limited (HKG:3692) After Its Half-Year Results

Simply Wall St.
·
Aug 29

China's Zhaoke Ophthalmology H1 Revenue Rises

Reuters
·
Aug 28

China's CStone Pharmaceuticals H1 Revenue Soars on Drug Sales

Reuters
·
Aug 27

China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales

Reuters
·
Aug 27